Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer

References

• Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell 2010; 40:179 - 204; http://dx.doi.org/10.1016/j.molcel.2010.09.019; PMID: 20965415
   PubMed Web of Science ®Google Scholar
• Hoeijmakers JH. DNA damage, aging, and cancer. N Engl J Med 2009; 361:1475 - 85; http://dx.doi.org/10.1056/NEJMra0804615; PMID: 19812404
   PubMed Web of Science ®Google Scholar
• Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003; 22:7265 - 79; http://dx.doi.org/10.1038/sj.onc.1206933; PMID: 14576837
   PubMed Web of Science ®Google Scholar
• Pan Y, Zhang Q, Atsaves V, Yang H, Claret FX. Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways. Oncogene 2013; 32:2756 - 66; http://dx.doi.org/10.1038/onc.2012.294; PMID: 22797071
   PubMed Web of Science ®Google Scholar
• Tian L, Peng G, Parant JM, Leventaki V, Drakos E, Zhang Q, Parker-Thornburg J, Shackleford TJ, Dai H, Lin SY, et al. Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair. Oncogene 2010; 29:6125 - 37; http://dx.doi.org/10.1038/onc.2010.345; PMID: 20802511
   PubMed Web of Science ®Google Scholar
• Pan Y, Claret FX. Targeting Jab1/CSN5 in nasopharyngeal carcinoma. Cancer Lett 2012; 326:155 - 60; http://dx.doi.org/10.1016/j.canlet.2012.07.033; PMID: 22867945
   PubMed Web of Science ®Google Scholar
• Pan Y, Zhang Q, Tian L, Wang X, Fan X, Zhang H, Claret FX, Yang H. Jab1/CSN5 negatively regulates p27 and plays a role in the pathogenesis of nasopharyngeal carcinoma. Cancer Res 2012; 72:1890 - 900; http://dx.doi.org/10.1158/0008-5472.CAN-11-3472; PMID: 22350412
   PubMed Web of Science ®Google Scholar
• Sakamoto K, Tominaga Y, Yamauchi K, Nakatsu Y, Sakumi K, Yoshiyama K, Egashira A, Kura S, Yao T, Tsuneyoshi M, et al. MUTYH-null mice are susceptible to spontaneous and oxidative stress induced intestinal tumorigenesis. Cancer Res 2007; 67:6599 - 604; http://dx.doi.org/10.1158/0008-5472.CAN-06-4802; PMID: 17638869
   PubMed Web of Science ®Google Scholar
• Matoka DJ, Yao V, Harya DS, Gregg JL, Robinson AR, Niedernhofer LJ, Parwani AV, Maier C, Bacich DJ. Deficiency of DNA repair nuclease ERCC1-XPF promotes prostate cancer progression in a tissue recombination model. Prostate 2012; 72:1214 - 22; http://dx.doi.org/10.1002/pros.22472; PMID: 22212909
   PubMed Web of Science ®Google Scholar
• Goldsby RE, Lawrence NA, Hays LE, Olmsted EA, Chen X, Singh M, Preston BD. Defective DNA polymerase-delta proofreading causes cancer susceptibility in mice. Nat Med 2001; 7:638 - 9; http://dx.doi.org/10.1038/88963; PMID: 11385474
   PubMed Web of Science ®Google Scholar
• Lin Q, Clark AB, McCulloch SD, Yuan T, Bronson RT, Kunkel TA, Kucherlapati R. Increased susceptibility to UV-induced skin carcinogenesis in polymerase eta-deficient mice. Cancer Res 2006; 66:87 - 94; http://dx.doi.org/10.1158/0008-5472.CAN-05-1862; PMID: 16397220
   PubMed Web of Science ®Google Scholar
• Kuznetsov SG, Haines DC, Martin BK, Sharan SK. Loss of Rad51c leads to embryonic lethality and modulation of Trp53-dependent tumorigenesis in mice. Cancer Res 2009; 69:863 - 72; http://dx.doi.org/10.1158/0008-5472.CAN-08-3057; PMID: 19155299
   PubMed Web of Science ®Google Scholar
• Wang Y, Putnam CD, Kane MF, Zhang W, Edelmann L, Russell R, Carrión DV, Chin L, Kucherlapati R, Kolodner RD, et al. Mutation in Rpa1 results in defective DNA double-strand break repair, chromosomal instability and cancer in mice. Nat Genet 2005; 37:750 - 5; http://dx.doi.org/10.1038/ng1587; PMID: 15965476
   PubMed Web of Science ®Google Scholar
• Bouwman P, Jonkers J. The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance. Nat Rev Cancer 2012; 12:587 - 98; http://dx.doi.org/10.1038/nrc3342; PMID: 22918414
   PubMed Web of Science ®Google Scholar
• Moynahan ME, Pierce AJ, Jasin M. BRCA2 is required for homology-directed repair of chromosomal breaks. Mol Cell 2001; 7:263 - 72; http://dx.doi.org/10.1016/S1097-2765(01)00174-5; PMID: 11239455
   PubMed Web of Science ®Google Scholar
• Fackenthal JD, Olopade OI. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 2007; 7:937 - 48; http://dx.doi.org/10.1038/nrc2054; PMID: 18034184
   PubMed Web of Science ®Google Scholar
• Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266:66 - 71; http://dx.doi.org/10.1126/science.7545954; PMID: 7545954
   PubMed Web of Science ®Google Scholar
• Moynahan ME, Jasin M. Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat Rev Mol Cell Biol 2010; 11:196 - 207; http://dx.doi.org/10.1038/nrm2851; PMID: 20177395
   PubMed Web of Science ®Google Scholar
• Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75:1027 - 38; http://dx.doi.org/10.1016/0092-8674(93)90546-3; PMID: 8252616
   PubMed Web of Science ®Google Scholar
• Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, et al. Mutation of a mutL homolog in hereditary colon cancer. Science 1994; 263:1625 - 9; http://dx.doi.org/10.1126/science.8128251; PMID: 8128251
   PubMed Web of Science ®Google Scholar
• Spry M, Scott T, Pierce H, D’Orazio JA. DNA repair pathways and hereditary cancer susceptibility syndromes. Front Biosci 2007; 12:4191 - 207; http://dx.doi.org/10.2741/2380; PMID: 17485367
   PubMed Web of Science ®Google Scholar
• Levy-Lahad E. Fanconi anemia and breast cancer susceptibility meet again. Nat Genet 2010; 42:368 - 9; http://dx.doi.org/10.1038/ng0510-368; PMID: 20428093
   PubMed Web of Science ®Google Scholar
• Walsh T, King MC. Ten genes for inherited breast cancer. Cancer Cell 2007; 11:103 - 5; http://dx.doi.org/10.1016/j.ccr.2007.01.010; PMID: 17292821
   PubMed Web of Science ®Google Scholar
• Moldovan GL, D’Andrea AD. How the fanconi anemia pathway guards the genome. Annu Rev Genet 2009; 43:223 - 49; http://dx.doi.org/10.1146/annurev-genet-102108-134222; PMID: 19686080
   PubMed Web of Science ®Google Scholar
• Slyskova J, Korenkova V, Collins AR, Prochazka P, Vodickova L, Svec J, Lipska L, Levy M, Schneiderova M, Liska V, et al. Functional, genetic, and epigenetic aspects of base and nucleotide excision repair in colorectal carcinomas. Clin Cancer Res 2012; 18:5878 - 87; http://dx.doi.org/10.1158/1078-0432.CCR-12-1380; PMID: 22966016
   PubMed Web of Science ®Google Scholar
• Nussenzweig A, Nussenzweig MC. Origin of chromosomal translocations in lymphoid cancer. Cell 2010; 141:27 - 38; http://dx.doi.org/10.1016/j.cell.2010.03.016; PMID: 20371343
   PubMed Web of Science ®Google Scholar
• Adler AS, Lin M, Horlings H, Nuyten DS, van de Vijver MJ, Chang HY. Genetic regulators of large-scale transcriptional signatures in cancer. Nat Genet 2006; 38:421 - 30; http://dx.doi.org/10.1038/ng1752; PMID: 16518402
   PubMed Web of Science ®Google Scholar
• Luo J, Solimini NL, Elledge SJ. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 2009; 136:823 - 37; http://dx.doi.org/10.1016/j.cell.2009.02.024; PMID: 19269363
   PubMed Web of Science ®Google Scholar
• Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008; 455:1069 - 75; http://dx.doi.org/10.1038/nature07423; PMID: 18948947
   PubMed Web of Science ®Google Scholar
• Martin LP, Hamilton TC, Schilder RJ. Platinum resistance: the role of DNA repair pathways. Clin Cancer Res 2008; 14:1291 - 5; http://dx.doi.org/10.1158/1078-0432.CCR-07-2238; PMID: 18316546
   PubMed Web of Science ®Google Scholar
• Neijenhuis S, Verwijs-Janssen M, van den Broek LJ, Begg AC, Vens C. Targeted radiosensitization of cells expressing truncated DNA polymerase beta. Cancer Res 2010; 70:8706 - 14; http://dx.doi.org/10.1158/0008-5472.CAN-09-3901; PMID: 20978197
   PubMed Web of Science ®Google Scholar
• Audeh MW, Carmichael J, Penson RT, Friedlander M, Powell B, Bell-McGuinn KM, Scott C, Weitzel JN, Oaknin A, Loman N, et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet 2010; 376:245 - 51; http://dx.doi.org/10.1016/S0140-6736(10)60893-8; PMID: 20609468
   PubMed Web of Science ®Google Scholar
• Tutt A, Robson M, Garber JE, Domchek SM, Audeh MW, Weitzel JN, Friedlander M, Arun B, Loman N, Schmutzler RK, et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet 2010; 376:235 - 44; http://dx.doi.org/10.1016/S0140-6736(10)60892-6; PMID: 20609467
   PubMed Web of Science ®Google Scholar
• Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005; 434:917 - 21; http://dx.doi.org/10.1038/nature03445; PMID: 15829967
   PubMed Web of Science ®Google Scholar
• Bolderson E, Richard DJ, Zhou BB, Khanna KK. Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair. Clin Cancer Res 2009; 15:6314 - 20; http://dx.doi.org/10.1158/1078-0432.CCR-09-0096; PMID: 19808869
   PubMed Web of Science ®Google Scholar
• Jiang H, Reinhardt HC, Bartkova J, Tommiska J, Blomqvist C, Nevanlinna H, Bartek J, Yaffe MB, Hemann MT. The combined status of ATM and p53 link tumor development with therapeutic response. Genes Dev 2009; 23:1895 - 909; http://dx.doi.org/10.1101/gad.1815309; PMID: 19608766
   PubMed Web of Science ®Google Scholar
• Martin SA, Hewish M, Lord CJ, Ashworth A. Genomic instability and the selection of treatments for cancer. J Pathol 2010; 220:281 - 9; PMID: 19890832
   PubMed Web of Science ®Google Scholar
• Chamovitz DA, Wei N, Osterlund MT, von Arnim AG, Staub JM, Matsui M, Deng XW. The COP9 complex, a novel multisubunit nuclear regulator involved in light control of a plant developmental switch. Cell 1996; 86:115 - 21; http://dx.doi.org/10.1016/S0092-8674(00)80082-3; PMID: 8689678
   PubMed Web of Science ®Google Scholar
• Karniol B, Chamovitz DA. The COP9 signalosome: from light signaling to general developmental regulation and back. Curr Opin Plant Biol 2000; 3:387 - 93; http://dx.doi.org/10.1016/S1369-5266(00)00101-1; PMID: 11019806
   PubMed Web of Science ®Google Scholar
• Chamovitz DA, Segal D. JAB1/CSN5 and the COP9 signalosome. A complex situation. EMBO Rep 2001; 2:96 - 101; http://dx.doi.org/10.1093/embo-reports/kve028; PMID: 11258719
   PubMed Web of Science ®Google Scholar
• Yu YS, Tang ZH, Pan QC, Chen XH, Liu XN, Zang GQ. Inhibition of Csn3 expression induces growth arrest and apoptosis of hepatocellular carcinoma cells. Cancer Chemother Pharmacol 2012; 69:1173 - 80; http://dx.doi.org/10.1007/s00280-011-1810-x; PMID: 22237956
   PubMed Web of Science ®Google Scholar
• Yoneda-Kato N, Tomoda K, Umehara M, Arata Y, Kato JY. Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3. EMBO J 2005; 24:1739 - 49; http://dx.doi.org/10.1038/sj.emboj.7600656; PMID: 15861129
   PubMed Web of Science ®Google Scholar
• Luo J, Emanuele MJ, Li D, Creighton CJ, Schlabach MR, Westbrook TF, Wong KK, Elledge SJ. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 2009; 137:835 - 48; http://dx.doi.org/10.1016/j.cell.2009.05.006; PMID: 19490893
   PubMed Web of Science ®Google Scholar
• Claret FX, Hibi M, Dhut S, Toda T, Karin M. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 1996; 383:453 - 7; http://dx.doi.org/10.1038/383453a0; PMID: 8837781
   PubMed Web of Science ®Google Scholar
• Wei N, Deng XW. The COP9 signalosome. Annu Rev Cell Dev Biol 2003; 19:261 - 86; http://dx.doi.org/10.1146/annurev.cellbio.19.111301.112449; PMID: 14570571
   PubMed Web of Science ®Google Scholar
• Freilich S, Oron E, Kapp Y, Nevo-Caspi Y, Orgad S, Segal D, Chamovitz DA. The COP9 signalosome is essential for development of Drosophila melanogaster. Curr Biol 1999; 9:1187 - 90; http://dx.doi.org/10.1016/S0960-9822(00)80023-8; PMID: 10531038
   PubMed Web of Science ®Google Scholar
• Kwok SF, Solano R, Tsuge T, Chamovitz DA, Ecker JR, Matsui M, Deng XW. Arabidopsis homologs of a c-Jun coactivator are present both in monomeric form and in the COP9 complex, and their abundance is differentially affected by the pleiotropic cop/det/fus mutations. Plant Cell 1998; 10:1779 - 90; PMID: 9811788
   PubMed Web of Science ®Google Scholar
• Bennett EJ, Rush J, Gygi SP, Harper JW. Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics. Cell 2010; 143:951 - 65; http://dx.doi.org/10.1016/j.cell.2010.11.017; PMID: 21145461
   PubMed Web of Science ®Google Scholar
• Sharon M, Mao H, Boeri Erba E, Stephens E, Zheng N, Robinson CV. Symmetrical modularity of the COP9 signalosome complex suggests its multifunctionality. Structure 2009; 17:31 - 40; http://dx.doi.org/10.1016/j.str.2008.10.012; PMID: 19141280
   PubMed Web of Science ®Google Scholar
• Tomoda K, Kubota Y, Arata Y, Mori S, Maeda M, Tanaka T, Yoshida M, Yoneda-Kato N, Kato JY. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J Biol Chem 2002; 277:2302 - 10; http://dx.doi.org/10.1074/jbc.M104431200; PMID: 11704659
   PubMed Web of Science ®Google Scholar
• Bounpheng MA, Melnikova IN, Dodds SG, Chen H, Copeland NG, Gilbert DJ, Jenkins NA, Christy BA. Characterization of the mouse JAB1 cDNA and protein. Gene 2000; 242:41 - 50; http://dx.doi.org/10.1016/S0378-1119(99)00525-9; PMID: 10721695
   PubMed Web of Science ®Google Scholar
• Maytal-Kivity V, Piran R, Pick E, Hofmann K, Glickman MH. COP9 signalosome components play a role in the mating pheromone response of S. cerevisiae. EMBO Rep 2002; 3:1215 - 21; http://dx.doi.org/10.1093/embo-reports/kvf235; PMID: 12446563
   PubMed Web of Science ®Google Scholar
• Wei N, Serino G, Deng XW. The COP9 signalosome: more than a protease. Trends Biochem Sci 2008; 33:592 - 600; http://dx.doi.org/10.1016/j.tibs.2008.09.004; PMID: 18926707
   PubMed Web of Science ®Google Scholar
• Adler AS, Littlepage LE, Lin M, Kawahara TL, Wong DJ, Werb Z, Chang HY. CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression. Cancer Res 2008; 68:506 - 15; http://dx.doi.org/10.1158/0008-5472.CAN-07-3060; PMID: 18199546
   PubMed Web of Science ®Google Scholar
• Savvides SN, Scheiwein M, Bohme CC, Arteel GE, Karplus PA, Becker K, Schirmer RH. Crystal structure of the antioxidant enzyme glutathione reductase inactivated by peroxynitrite. J Biol Chem 2002; 277:2779 - 84; http://dx.doi.org/10.1074/jbc.M108190200; PMID: 11705998
   PubMed Web of Science ®Google Scholar
• Hallstrom TC, Nevins JR. Jab1 is a specificity factor for E2F1-induced apoptosis. Genes Dev 2006; 20:613 - 23; http://dx.doi.org/10.1101/gad.1345006; PMID: 16481464
   PubMed Web of Science ®Google Scholar
• Shackleford TJ, Claret FX. JAB1/CSN5: a new player in cell cycle control and cancer. Cell Div 2010; 5:26; http://dx.doi.org/10.1186/1747-1028-5-26; PMID: 20955608
   PubMed Web of Science ®Google Scholar
• Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tai Y, Tokuda M. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors. Clin Cancer Res 2001; 7:4130 - 5; PMID: 11751512
   PubMed Web of Science ®Google Scholar
• Hsu MC, Huang CC, Chang HC, Hu TH, Hung WC. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptorgamma ligands in vitro and in vivo. Clin Cancer Res 2008; 14:4045 - 52; http://dx.doi.org/10.1158/1078-0432.CCR-07-5040; PMID: 18593980
   PubMed Web of Science ®Google Scholar
• Osoegawa A, Yoshino I, Kometani T, Yamaguchi M, Kameyama T, Yohena T, Maehara Y. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features. Cancer 2006; 107:154 - 61; http://dx.doi.org/10.1002/cncr.21961; PMID: 16721818
   PubMed Web of Science ®Google Scholar
• Kouvaraki MA, Korapati AL, Rassidakis GZ, Tian L, Zhang Q, Chiao P, Ho L, Evans DB, Claret FX. Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma. Cancer Res 2006; 66:8581 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-06-0975; PMID: 16951171
   PubMed Web of Science ®Google Scholar
• Kouvaraki MA, Rassidakis GZ, Tian L, Kumar R, Kittas C, Claret FX. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1). Cancer Res 2003; 63:2977 - 81; PMID: 12782606
   PubMed Web of Science ®Google Scholar
• Gao L, Huang S, Ren W, Zhao L, Li J, Zhi K, Zhang Y, Qi H, Huang C. Jun activation domain-binding protein 1 expression in oral squamous cell carcinomas inversely correlates with the cell cycle inhibitor p27. Med Oncol 2012; 29:2499 - 504; http://dx.doi.org/10.1007/s12032-012-0177-0; PMID: 22311264
   PubMed Web of Science ®Google Scholar
• Ahn J, Hong SA, Lee SE, Kim J, Oh YS, Park SJ, Chung YJ. Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma. Endocr J 2009; 56:707 - 13; http://dx.doi.org/10.1507/endocrj.K08E-372; PMID: 19461157
   PubMed Web of Science ®Google Scholar
• Michel JJ, Xiong Y. Human CUL-1, but not other cullin family members, selectively interacts with SKP1 to form a complex with SKP2 and cyclin A. Cell Growth Differ 1998; 9:435 - 49; PMID: 9663463
   PubMedGoogle Scholar
• Nayak S, Santiago FE, Jin H, Lin D, Schedl T, Kipreos ET. The Caenorhabditis elegans Skp1-related gene family: diverse functions in cell proliferation, morphogenesis, and meiosis. Curr Biol 2002; 12:277 - 87; http://dx.doi.org/10.1016/S0960-9822(02)00682-6; PMID: 11864567
   PubMed Web of Science ®Google Scholar
• Fischer ES, Scrima A, Böhm K, Matsumoto S, Lingaraju GM, Faty M, Yasuda T, Cavadini S, Wakasugi M, Hanaoka F, et al. The molecular basis of CRL4DDB2/CSA ubiquitin ligase architecture, targeting, and activation. Cell 2011; 147:1024 - 39; http://dx.doi.org/10.1016/j.cell.2011.10.035; PMID: 22118460
   PubMed Web of Science ®Google Scholar
• Groisman R, Polanowska J, Kuraoka I, Sawada J, Saijo M, Drapkin R, Kisselev AF, Tanaka K, Nakatani Y. The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell 2003; 113:357 - 67; http://dx.doi.org/10.1016/S0092-8674(03)00316-7; PMID: 12732143
   PubMed Web of Science ®Google Scholar
• Parrilla-Castellar ER, Arlander SJ, Karnitz L. Dial 9-1-1 for DNA damage: the Rad9-Hus1-Rad1 (9-1-1) clamp complex. DNA Repair (Amst) 2004; 3:1009 - 14; http://dx.doi.org/10.1016/j.dnarep.2004.03.032; PMID: 15279787
   PubMed Web of Science ®Google Scholar
• Huang J, Yuan H, Lu C, Liu X, Cao X, Wan M. Jab1 mediates protein degradation of the Rad9-Rad1-Hus1 checkpoint complex. J Mol Biol 2007; 371:514 - 27; http://dx.doi.org/10.1016/j.jmb.2007.05.095; PMID: 17583730
   PubMed Web of Science ®Google Scholar
• Melo J, Toczyski D. A unified view of the DNA-damage checkpoint. Curr Opin Cell Biol 2002; 14:237 - 45; http://dx.doi.org/10.1016/S0955-0674(02)00312-5; PMID: 11891124
   PubMed Web of Science ®Google Scholar
• Ghabrial A, Ray RP, Schüpbach T. okra and spindle-B encode components of the RAD52 DNA repair pathway and affect meiosis and patterning in Drosophila oogenesis. Genes Dev 1998; 12:2711 - 23; http://dx.doi.org/10.1101/gad.12.17.2711; PMID: 9732269
   PubMed Web of Science ®Google Scholar
• Doronkin S, Djagaeva I, Beckendorf SK. CSN5/Jab1 mutations affect axis formation in the Drosophila oocyte by activating a meiotic checkpoint. Development 2002; 129:5053 - 64; PMID: 12397113
   PubMed Web of Science ®Google Scholar
• McKim KS, Hayashi-Hagihara A. mei-W68 in Drosophila melanogaster encodes a Spo11 homolog: evidence that the mechanism for initiating meiotic recombination is conserved. Genes Dev 1998; 12:2932 - 42; http://dx.doi.org/10.1101/gad.12.18.2932; PMID: 9744869
   PubMed Web of Science ®Google Scholar
• Shinohara A, Ogawa H, Ogawa T. Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein. Cell 1992; 69:457 - 70; http://dx.doi.org/10.1016/0092-8674(92)90447-K; PMID: 1581961
   PubMed Web of Science ®Google Scholar
• Buscemi G, Perego P, Carenini N, Nakanishi M, Chessa L, Chen J, Khanna K, Delia D. Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks. Oncogene 2004; 23:7691 - 700; http://dx.doi.org/10.1038/sj.onc.1207986; PMID: 15361830
   PubMed Web of Science ®Google Scholar
• Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273:5858 - 68; http://dx.doi.org/10.1074/jbc.273.10.5858; PMID: 9488723
   PubMed Web of Science ®Google Scholar
• Lee EW, Lee S, Song J. Jab1 has negative effects on p53-mediated genotoxic stresses. BMB Rep 2009; 42:299 - 303; http://dx.doi.org/10.5483/BMBRep.2009.42.5.299; PMID: 19470245
   PubMed Web of Science ®Google Scholar
• Wang B, Matsuoka S, Carpenter PB, Elledge SJ. 53BP1, a mediator of the DNA damage checkpoint. Science 2002; 298:1435 - 8; http://dx.doi.org/10.1126/science.1076182; PMID: 12364621
   PubMed Web of Science ®Google Scholar
• Wang F, Wang Y, Yu X, Yang D, Wang Z, Lu C, Yuan Z, Xiao M, Shen A. Significance of Jab1 expression in human esophageal squamous cell carcinoma. J Clin Gastroenterol 2009; 43:520 - 6; http://dx.doi.org/10.1097/MCG.0b013e3181919245; PMID: 19349901
   PubMed Web of Science ®Google Scholar
• Dong Y, Sui L, Watanabe Y, Yamaguchi F, Hatano N, Tokuda M. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas. Clin Cancer Res 2005; 11:259 - 66; PMID: 15671554
   PubMed Web of Science ®Google Scholar
• Hsu MC, Chang HC, Hung WC. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells. Endocr Relat Cancer 2007; 14:655 - 67; http://dx.doi.org/10.1677/ERC-07-0077; PMID: 17914096
   PubMed Web of Science ®Google Scholar
• Tomoda K, Yoneda-Kato N, Fukumoto A, Yamanaka S, Kato JY. Multiple functions of Jab1 are required for early embryonic development and growth potential in mice. J Biol Chem 2004; 279:43013 - 8; http://dx.doi.org/10.1074/jbc.M406559200; PMID: 15299027
   PubMed Web of Science ®Google Scholar
• Sitte S, Gläsner J, Jellusova J, Weisel F, Panattoni M, Pardi R, Gessner A. JAB1 is essential for B cell development and germinal center formation and inversely regulates Fas ligand and Bcl6 expression. J Immunol 2012; 188:2677 - 86; http://dx.doi.org/10.4049/jimmunol.1101455; PMID: 22327073
   PubMed Web of Science ®Google Scholar
• Wang H, Song W, Hu T, Zhang N, Miao S, Zong S, Wang L. Fank1 interacts with Jab1 and regulates cell apoptosis via the AP-1 pathway. Cell Mol Life Sci 2011; 68:2129 - 39; http://dx.doi.org/10.1007/s00018-010-0559-4; PMID: 20978819
   PubMed Web of Science ®Google Scholar
• Li J, Wang Y, Yang C, Wang P, Oelschlager DK, Zheng Y, Tian DA, Grizzle WE, Buchsbaum DJ, Wan M. Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1. Mol Pharmacol 2009; 76:81 - 90; http://dx.doi.org/10.1124/mol.109.054551; PMID: 19395473
   PubMed Web of Science ®Google Scholar
• Pan Y, Wang M, Bu X, Zuo Y, Wang S, Wang D, Liu Q, Su B, Xu T, Wang C, et al. Curcumin analogue T83 exhibits potent antitumor activity and induces radiosensitivity through inactivation of Jab1 in nasopharyngeal carcinoma. BMC Cancer 2013; 13:323; http://dx.doi.org/10.1186/1471-2407-13-323; PMID: 23815987
   PubMed Web of Science ®Google Scholar